Skip to content
Stop using now Medical device recall · FDA · Published November 2, 2025

Medtronic MiniMed 780G Recall: Software Error Stops Insulin Delivery

Medtronic recalls specific MiniMed 780G insulin pumps due to software errors that may suspend insulin delivery. Check your model and serial number.

🇺🇸 FDA recall #Z-1238-2026Medical deviceMedtronic MiniMed ›
Take action

Contact the company

Recalling firmMedtronic MiniMed, Inc.18000 Devonshire St · Northridge, CA 91325-1219
✎ GovInfoNow plain-language explainer

Medtronic MiniMed is recalling the MiniMed 780G insulin pump because a software timing issue can cause Pump Error 43 or Pump Error 41, which stops insulin from being delivered. This affects pumps with catalog numbers MMT-1884 and MMT-1886 that have software version 6.60 installed. The recall covers 577 units distributed in the U.S. and Israel. Read more at govinfonow.com/recall/50828-medtronic-minimed-780g-insulin-pump-software-version-6-60-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/50828-medtronic-minimed-780g-insulin-pump-software-version-6-60-recall · Updated October 13, 2026 · FDA enforcement record: FDA #Z-1238-2026

Cite this page

“Medtronic MiniMed 780G Recall: Software Error Stops Insulin Delivery.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/50828-medtronic-minimed-780g-insulin-pump-software-version-6-60-recall. Based on FDA recall #Z-1238-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1238-2026%22&limit=1).

The FDA announced on Nov. 2, 2025, that Medtronic MiniMed, Inc. is recalling MiniMed 780G insulin pumps due to a software issue that may suspend insulin delivery. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Medtronic
  • Product: MiniMed 780G Insulin Pump
  • Catalog Numbers: MMT-1884, MMT-1886
  • Software Version: 6.60
  • Units affected: 577

The hazard

A software timing and processor communication issue in MiniMed 780G software version 6.60 may trigger Pump Error 43 and/or Pump Error 41, resulting in suspension of insulin delivery.

Context

GovInfoNow's records show Medtronic MiniMed, Inc. has 13 other recalls on record since 2023-11-15. Other recent recalls of similar products include Medtronic MiniMed 780G Insulin Pump Recall: Software Error Causes Insulin Stoppage (2026-05-27), Medtronic MiniMed Go App Version 1.0.0/1.1.0 May Cause Missed Insulin Doses (2026-06-16), and Medtronic MiniMed 670G Insulin Pump Recall: Risk of Incorrect Insulin Delivery (2026-07-13). FDA's MAUDE device-report database contains 108,633 reports in FDA's MAUDE database naming MiniMed 780G (product code OZP), received since November 2024, 18,425 of them marked serious and 94 listing a death.

How to tell if you have this one

Check if your device is a MiniMed 780G Insulin Pump with catalog number MMT-1884 or MMT-1886 and software version 6.60. You can verify the specific serial numbers affected by visiting the official recall notice, as there are hundreds of unique serial numbers listed for both U.S. and Israel distributions.

  • Brand
    Medtronic MiniMed
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Your Device Details

    Verify if your MiniMed 780G pump has catalog number MMT-1884 or MMT-1886 with software version 6.60.

  2. Contact Medtronic for Remedy

    The recall record does not specify the current remedy steps; contact Medtronic MiniMed directly for instructions on how to proceed with your specific unit.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 45 states.

Alaska: nationwideAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide - U.S. National distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Nov 2, 202512. FDA classified it Class II: Feb 2, 202623. Published in FDA’s Enforcement Report: Feb 11, 2026320252026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where were these pumps sold?

The pumps were distributed worldwide, including national distribution across all U.S. states and in the country of Israel.

Similar recalls

Other Medtronic MiniMed recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1238-2026 (November 2, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1238-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA